1. Home
  2. WEAV vs RCKT Comparison

WEAV vs RCKT Comparison

Compare WEAV & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

HOLD

Current Price

$7.19

Market Cap

413.7M

Sector

Technology

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.45

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEAV
RCKT
Founded
2011
1999
Country
United States
United States
Employees
N/A
202
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
413.7M
401.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
WEAV
RCKT
Price
$7.19
$3.45
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$11.00
$29.73
AVG Volume (30 Days)
1.1M
3.1M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
7.50
N/A
EPS
N/A
N/A
Revenue
$239,024,000.00
N/A
Revenue This Year
$17.20
N/A
Revenue Next Year
$13.74
$64.28
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$4.24
$2.53
52 Week High
$8.28
$5.45

Technical Indicators

Market Signals
Indicator
WEAV
RCKT
Relative Strength Index (RSI) 68.86 47.98
Support Level $6.94 $3.36
Resistance Level $7.31 $3.56
Average True Range (ATR) 0.31 0.24
MACD 0.06 -0.06
Stochastic Oscillator 72.21 18.22

Price Performance

Historical Comparison
WEAV
RCKT

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and generates revenue mainly from subscriptions.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: